328 related articles for article (PubMed ID: 33377442)
1. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
2. Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.
Perfetto EM; Anyanwu C; Pickering MK; Zaghab RW; Graff JS; Eichelberger B
J Manag Care Spec Pharm; 2016 Jun; 22(6):609-16. PubMed ID: 27231789
[TBL] [Abstract][Full Text] [Related]
3. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
J Manag Care Spec Pharm; 2020 Dec; 26(12):1604-1611. PubMed ID: 33251991
[TBL] [Abstract][Full Text] [Related]
4. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
J Manag Care Spec Pharm; 2017 Jun; 23(6):613-620. PubMed ID: 28530524
[TBL] [Abstract][Full Text] [Related]
5. Use of real-world evidence in economic assessments of pharmaceuticals in the United States.
Lee W; Dayer V; Jiao B; Carlson JJ; Devine B; Veenstra DL
J Manag Care Spec Pharm; 2021 Jan; 27(1):5-14. PubMed ID: 33377439
[No Abstract] [Full Text] [Related]
6. Payer perceptions of the use of real-world evidence in oncology-based decision making.
Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
[No Abstract] [Full Text] [Related]
7. The use of real-world evidence in ICER's scoping process and clinical evidence assessments.
Jiao B; Veenstra DL; Lee W; Carlson JJ; Devine B
J Manag Care Spec Pharm; 2020 Dec; 26(12):1590-1595. PubMed ID: 33251999
[No Abstract] [Full Text] [Related]
8. The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness.
Dreyer NA; Bryant A; Velentgas P
J Manag Care Spec Pharm; 2016 Oct; 22(10):1107-13. PubMed ID: 27668559
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions.
Pearson SD; Dreitlein WB; Towse A; Hampson G; Henshall C
J Comp Eff Res; 2018 Dec; 7(12):1145-1152. PubMed ID: 30427724
[TBL] [Abstract][Full Text] [Related]
11. A novel tool to assess the quality of RWE to guide the management of retinal disease.
Finger RP; Daien V; Talks JS; Mitchell P; Wong TY; Sakamoto T; Eldem BM; Lövestam-Adrian M; Korobelnik JF
Acta Ophthalmol; 2021 Sep; 99(6):604-610. PubMed ID: 33369881
[TBL] [Abstract][Full Text] [Related]
12. Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.
Makady A; Stegenga H; Ciaglia A; Debray TP; Lees M; Happich M; Ryll B; Abrams K; Thwaites R; Garner S; Jonsson P; Goettsch W
J Comp Eff Res; 2017 Sep; 6(6):485-490. PubMed ID: 28857631
[TBL] [Abstract][Full Text] [Related]
13. Ability and Use of Comparative Effectiveness Research by P&T Committee Members and Support Staff: A 1-Year Follow-up.
Augustine J; Warholak TL; Hines LE; Sun D; Brown M; Hurwitz J; Taylor AM; Brixner D; Cobaugh DJ; Schlaifer M; Malone DC
J Manag Care Spec Pharm; 2016 Jun; 22(6):618-25. PubMed ID: 27231790
[TBL] [Abstract][Full Text] [Related]
14. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
15. Implementing CER: what will it take?
Biskupiak JE; Dunn JD; Holtorf AP
J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design.
Xia AD; Schaefer CP; Szende A; Jahn E; Hirst MJ
Drugs Real World Outcomes; 2019 Dec; 6(4):193-203. PubMed ID: 31741199
[TBL] [Abstract][Full Text] [Related]
18. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
